CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $44,000 | -42.9% | 18,528 | -13.7% | 0.00% | – |
| Q1 2017 | $77,000 | -8.3% | 21,479 | -9.0% | 0.00% | – |
| Q4 2016 | $84,000 | -19.2% | 23,596 | -8.1% | 0.00% | – |
| Q3 2016 | $104,000 | -18.1% | 25,688 | -10.6% | 0.00% | – |
| Q2 2016 | $127,000 | +3.3% | 28,718 | -11.5% | 0.00% | – |
| Q1 2016 | $123,000 | -97.4% | 32,436 | -89.5% | 0.00% | -100.0% |
| Q4 2015 | $4,823,000 | +10.4% | 307,620 | -25.8% | 0.01% | +7.7% |
| Q3 2015 | $4,368,000 | -51.2% | 414,412 | +16.6% | 0.01% | -40.9% |
| Q2 2015 | $8,960,000 | +20.4% | 355,279 | +33.0% | 0.02% | +22.2% |
| Q1 2015 | $7,443,000 | +45.7% | 267,065 | -4.6% | 0.02% | +38.5% |
| Q4 2014 | $5,107,000 | +55.5% | 279,850 | +10.4% | 0.01% | +62.5% |
| Q3 2014 | $3,285,000 | -6.6% | 253,445 | +17.6% | 0.01% | -11.1% |
| Q2 2014 | $3,518,000 | -16.5% | 215,572 | -9.6% | 0.01% | -25.0% |
| Q1 2014 | $4,212,000 | -11.2% | 238,364 | +21.7% | 0.01% | -14.3% |
| Q4 2013 | $4,742,000 | -16.4% | 195,848 | +22.4% | 0.01% | -30.0% |
| Q3 2013 | $5,671,000 | +88.5% | 160,060 | -16.9% | 0.02% | +53.8% |
| Q2 2013 | $3,008,000 | – | 192,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |